We are living in an unprecedented time of uncertainty, but decisions made now will have a tremendous impact on the social and economic wellbeing of society as the COVID pandemic evolves. While it is important to understand the limitations of available information on the crisis, smart data products can help to make rapid decisions on the best available evidence. Genesis has developed two data intelligence tools related to the COVID crisis which help decision makers, and anyone else who is interested, to understand how the crisis is unfolding and where actions may be required.
Is Africa Flattening the Curve?
Is Africa Flattening the Curve provides an interactive dashboard reporting on the spread of the virus, its fatality rate, and the response in testing across all African countries that have 100 cumulative cases or more. Compare the rate of spread of the virus across multiple countries, including your own selection of international benchmarks, or dive deeper into the spread of the virus at a provincial level in South Africa.
Healthcare Risk Calculator
The Healthcare Risk Calculator provides a quick tool for estimating the strain on the healthcare system by forecasting the amount of ICU beds that will be required over the next two weeks. Input your own data to see how your district, region or country's healthcare risk profile will likely evolve over the next two weeks. This is a useful tool to support decisions about healthcare resources and lockdown levels.
Measuring the prevalence of COVID in three SA areas
Genesis, in partnership with the NICD, PHRU and Epicentre, are excited to share the preliminary findings of the Healthcare UTilisation and Seroprevalence (HUTS) survey. The survey is currently running in the households of three South African communities (Maritzburg, Klerksdorp, and Mitchell's Plain). This report shows that 35.8% of survey participants had antibodies for COVID-19 as of 31 January 2021.
Statement from our CEO on Genesis during the COVID-19 pandemic
As the COVID-19 pandemic unfolds, Genesis is monitoring the evolving situation closely. Our teams have run various scenarios of the effects of the epidemic on the economies in which we operate our business. Genesis chair Stephan Malherbe outlines the position of the firm.